A platform designed for systemic delivery of immune-stimulatory transgenes and checkpoint inhibitors to distant and local tumors, featuring a chimeric adenoviral backbone for targeted cancer treatment.

An oncolytic immunotherapy platform that selectively kills tumor cells and releases tumor-derived antigens to promote a systemic anti-tumor immune response.